Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Syndicate
Aurora Cannabis 12M share Spot Secondary priced at $10.45 » 21:15
01/21/21
01/21
21:15
01/21/21
21:15
ACB

Aurora Cannabis

$11.17 /

-0.39 (-3.37%)

BMO Capital and ATB…

BMO Capital and ATB Capital Markets acted as joint book running managers for the offering.

ShowHide Related Items >><<
ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

01/06/21 BMO Capital
Federal cannabis reform in U.S. likely to take time, says BMO Capital
12/17/20 BMO Capital
Aurora Cannabis downgraded to Underperform from Market Perform at BMO Capital
12/04/20 Alliance Global Partners
Alliance Global sees low odds of MORE Act passing this congressional session
12/02/20 Alliance Global Partners
Alliance Global Partners sees UN cannabis reclassification helping legalization
ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

  • 22
    Jan
  • 11
    Nov
ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

On The Fly
Fly Intel: After-Hours Movers » 18:35
01/21/21
01/21
18:35
01/21/21
18:35
SIVB

SVB Financial

$455.02 /

-7.49 (-1.62%)

, WAL

Western Alliance

$69.40 /

-1.92 (-2.69%)

, INDB

Independent Bank

$78.68 /

-1.39 (-1.74%)

, OZK

Bank OZK

$34.03 /

-0.59 (-1.70%)

, FLDM

Fluidigm

$6.17 /

+0.31 (+5.29%)

, MNOV

MediciNova

$5.78 /

+0.09 (+1.58%)

, SWIR

Sierra Wireless

$18.41 /

+0.02 (+0.11%)

, ALDX

Aldeyra

$11.77 /

-0.48 (-3.92%)

, AMRN

Amarin

$6.31 /

+0.11 (+1.78%)

, IBM

IBM

$131.80 /

+1.72 (+1.32%)

, STX

Seagate

$63.00 /

+1.57 (+2.56%)

, PPG

PPG

$143.94 /

-0.635 (-0.44%)

, ISRG

Intuitive Surgical

$799.43 /

-0.18 (-0.02%)

, CSX

CSX

$91.61 /

-1.6101 (-1.73%)

, PGEN

Precigen

$9.18 /

-0.22 (-2.34%)

, ACB

Aurora Cannabis

$11.17 /

-0.39 (-3.37%)

, F

Ford

$11.53 /

+0.665 (+6.12%)

Check out this evening's…

ShowHide Related Items >><<
SWIR Sierra Wireless
$18.41 /

+0.02 (+0.11%)

STX Seagate
$63.00 /

+1.57 (+2.56%)

SIVB SVB Financial
$455.02 /

-7.49 (-1.62%)

PPG PPG
$143.94 /

-0.635 (-0.44%)

PGEN Precigen
$9.18 /

-0.22 (-2.34%)

OZK Bank OZK
$34.03 /

-0.59 (-1.70%)

MNOV MediciNova
$5.78 /

+0.09 (+1.58%)

ISRG Intuitive Surgical
$799.43 /

-0.18 (-0.02%)

IBM IBM
$131.80 /

+1.72 (+1.32%)

FLDM Fluidigm
$6.17 /

+0.31 (+5.29%)

F Ford
$11.53 /

+0.665 (+6.12%)

CSX CSX
$91.61 /

-1.6101 (-1.73%)

AMRN Amarin
$6.31 /

+0.11 (+1.78%)

ALDX Aldeyra
$11.77 /

-0.48 (-3.92%)

ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

SIVB SVB Financial
$455.02 /

-7.49 (-1.62%)

01/08/21 Oppenheimer
Oppenheimer calls SVB Financial acquisition of Boston Private a 'good move'
01/05/21 DA Davidson
SVB Financial price target raised to $400 from $365 at DA Davidson
01/05/21 Raymond James
SVB Financial price target raised to $440 from $325 at Raymond James
01/05/21 RBC Capital
SVB Financial price target raised to $437 from $320 at RBC Capital
WAL Western Alliance
$69.40 /

-1.92 (-2.69%)

01/08/21 UBS
Western Alliance upgraded to Buy from Neutral at UBS
01/04/21 Stephens
Brinker, LiveRamp and Vonage among 2021 best ideas at Stephens
12/15/20 Truist
Truist raises price targets on select regional banks
11/04/20 Stephens
Western Alliance resumed with an Overweight at Stephens
INDB Independent Bank
$78.68 /

-1.39 (-1.74%)

12/17/20 Seaport Global
Seaport Global rolls out coverage of Regional and Community Banks with 4 Buys
12/17/20 Seaport Global
Independent Bank initiated with a Neutral at Seaport Global
10/26/20 Compass Point
Independent Bank upgraded to Buy from Neutral at Compass Point
06/24/20 Piper Sandler
Independent Bank downgraded to Neutral from Overweight at Piper Sandler
OZK Bank OZK
$34.03 /

-0.59 (-1.70%)

06/17/20 Raymond James
Bank OZK upgraded to Outperform from Market Perform at Raymond James
06/17/20 Citi
Bank OZK downgraded to Neutral from Buy at Citi
06/17/20 Raymond James
Bank OZK upgraded to Outperform from Market Perform at Raymond James
04/28/20 Truist
Bank OZK price target raised to $22 from $19 at SunTrust
FLDM Fluidigm
$6.17 /

+0.31 (+5.29%)

12/17/20 BTIG
Illumina upgraded to Buy from Neutral at BTIG
11/09/20 Piper Sandler
Buy companies with COVID-19 tests on today's selloff, says Piper Sandler
10/19/20 Piper Sandler
Fluidigm test pact in Texas 'another validation,' says Piper Sandler
09/29/20 Piper Sandler
Piper Sandler would be buyers of Fluidigm given recent pullback
MNOV MediciNova
$5.78 /

+0.09 (+1.58%)

SWIR Sierra Wireless
$18.41 /

+0.02 (+0.11%)

01/14/21
Fly Intel: Top five analyst initiations
01/14/21 B. Riley Securities
Sierra Wireless initiated with a Buy at B. Riley Securities
11/25/20 Colliers
Sierra Wireless initiated with a Buy at Colliers
02/14/20 Roth Capital
Roth Capital sees upside in Sierra Wireless after 2020 transition year
ALDX Aldeyra
$11.77 /

-0.48 (-3.92%)

01/08/21 Jefferies
Aldeyra could double if topline of TRANQUILITY study positive, says Jefferies
01/08/21 Citi
Aldeyra shares have 'plenty of upside' despite 26% rally, says Citi
01/07/21 Alliance Global Partners
Aldeyra in an 'enviable position' after Phase 3 Tranquility data, says AGP
12/16/20 Berenberg
Berenberg starts Aldeyra with Buy, sees near-term catalysts
AMRN Amarin
$6.31 /

+0.11 (+1.78%)

01/08/21 Piper Sandler
Piper sees 're-birth' for Amarin shares in 2021, keeps $19 price target
12/28/20 Cantor Fitzgerald
Vascepa showing positive year-over-year trends, says Cantor Fitzgerald
12/23/20 Goldman Sachs
Amarin price target lowered to $6 from $8 at Goldman Sachs
12/14/20 Piper Sandler
Amarin's Vascepa showed 'encouraging results' in Covid patients, says Piper
IBM IBM
$131.80 /

+1.72 (+1.32%)

10/20/20 Morgan Stanley
Morgan Stanley continues to view IBM as 'a 2022 stock'
10/20/20 Citi
IBM is 'getting even more complex,' says Citi
10/20/20 BMO Capital
IBM price target lowered to $138 from $140 at BMO Capital
10/09/20 Morgan Stanley
IBM price target raised to $140 from $128 at Morgan Stanley
STX Seagate
$63.00 /

+1.57 (+2.56%)

01/21/21 Barclays
Seagate price target raised to $60 from $41 at Barclays
01/20/21 Wedbush
Seagate price target raised to $56 from $47 at Wedbush
01/19/21 Northland
Seagate price target raised to $72 from $65 at Northland
01/19/21 Loop Capital
Seagate price target raised to $70 from $60 at Loop Capital
PPG PPG
$143.94 /

-0.635 (-0.44%)

01/20/21 Citi
Citi adds PPG to US Focus List, removes FMC
01/14/21 Berenberg
PPG upgraded to Buy with $165 price target at Berenberg
01/14/21 Berenberg
PPG upgraded to Buy from Hold at Berenberg
12/01/20 Deutsche Bank
PPG price target raised to $165 from $155 at Deutsche Bank
ISRG Intuitive Surgical
$799.43 /

-0.18 (-0.02%)

12/15/20 Morgan Stanley
Intuitive Surgical downgraded to Equal Weight on valuation at Morgan Stanley
12/15/20 Morgan Stanley
Intuitive Surgical downgraded to Equal Weight from Overweight at Morgan Stanley
11/24/20 Raymond James
Intuitive Surgical not surprised by J&J robot features, says Raymond James
10/16/20 JPMorgan
Intuitive Surgical price target raised to $785 from $765 at JPMorgan
CSX CSX
$91.61 /

-1.6101 (-1.73%)

01/20/21 Susquehanna
Railroad recovery expected to continue in 2021, says Susquehanna
01/11/21 Citi
CSX price target raised to $105 from $87 at Citi
12/10/20 Morgan Stanley
Morgan Stanley downgrades CSX to Underweight with bar raised too high
12/10/20 Morgan Stanley
CSX downgraded to Underweight from Equal Weight at Morgan Stanley
PGEN Precigen
$9.18 /

-0.22 (-2.34%)

12/16/20 H.C. Wainwright
Precigen price target raised to $10 from $8 at H.C. Wainwright
05/08/20
Fly Intel: Top analyst initiations
05/08/20 H.C. Wainwright
Precigen initiated with a Buy at H.C. Wainwright
ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

01/06/21 BMO Capital
Federal cannabis reform in U.S. likely to take time, says BMO Capital
12/17/20 BMO Capital
Aurora Cannabis downgraded to Underperform from Market Perform at BMO Capital
12/04/20 Alliance Global Partners
Alliance Global sees low odds of MORE Act passing this congressional session
12/02/20 Alliance Global Partners
Alliance Global Partners sees UN cannabis reclassification helping legalization
F Ford
$11.53 /

+0.665 (+6.12%)

01/20/21 Deutsche Bank
Ford price target raised to $11 from $9 at Deutsche Bank
01/20/21 Deutsche Bank
Ford named 'Catalyst Call: Buy Idea' at Deutsche Bank
01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
12/23/20 Morgan Stanley
Apple's potential EV entry represents 'new Tesla bear case,' says Morgan Stanley
WAL Western Alliance
$69.40 /

-1.92 (-2.69%)

SWIR Sierra Wireless
$18.41 /

+0.02 (+0.11%)

STX Seagate
$63.00 /

+1.57 (+2.56%)

SIVB SVB Financial
$455.02 /

-7.49 (-1.62%)

PPG PPG
$143.94 /

-0.635 (-0.44%)

PGEN Precigen
$9.18 /

-0.22 (-2.34%)

OZK Bank OZK
$34.03 /

-0.59 (-1.70%)

ISRG Intuitive Surgical
$799.43 /

-0.18 (-0.02%)

INDB Independent Bank
$78.68 /

-1.39 (-1.74%)

IBM IBM
$131.80 /

+1.72 (+1.32%)

FLDM Fluidigm
$6.17 /

+0.31 (+5.29%)

F Ford
$11.53 /

+0.665 (+6.12%)

CSX CSX
$91.61 /

-1.6101 (-1.73%)

AMRN Amarin
$6.31 /

+0.11 (+1.78%)

ALDX Aldeyra
$11.77 /

-0.48 (-3.92%)

ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

  • 22
    Jan
  • 22
    Jan
  • 14
    Jan
  • 11
    Nov
IBM IBM
$131.80 /

+1.72 (+1.32%)

FLDM Fluidigm
$6.17 /

+0.31 (+5.29%)

F Ford
$11.53 /

+0.665 (+6.12%)

AMRN Amarin
$6.31 /

+0.11 (+1.78%)

ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

STX Seagate
$63.00 /

+1.57 (+2.56%)

SIVB SVB Financial
$455.02 /

-7.49 (-1.62%)

PPG PPG
$143.94 /

-0.635 (-0.44%)

MNOV MediciNova
$5.78 /

+0.09 (+1.58%)

ISRG Intuitive Surgical
$799.43 /

-0.18 (-0.02%)

IBM IBM
$131.80 /

+1.72 (+1.32%)

FLDM Fluidigm
$6.17 /

+0.31 (+5.29%)

F Ford
$11.53 /

+0.665 (+6.12%)

CSX CSX
$91.61 /

-1.6101 (-1.73%)

AMRN Amarin
$6.31 /

+0.11 (+1.78%)

ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

STX Seagate
$63.00 /

+1.57 (+2.56%)

PPG PPG
$143.94 /

-0.635 (-0.44%)

PGEN Precigen
$9.18 /

-0.22 (-2.34%)

MNOV MediciNova
$5.78 /

+0.09 (+1.58%)

ISRG Intuitive Surgical
$799.43 /

-0.18 (-0.02%)

IBM IBM
$131.80 /

+1.72 (+1.32%)

FLDM Fluidigm
$6.17 /

+0.31 (+5.29%)

F Ford
$11.53 /

+0.665 (+6.12%)

CSX CSX
$91.61 /

-1.6101 (-1.73%)

AMRN Amarin
$6.31 /

+0.11 (+1.78%)

ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

Syndicate
Aurora Cannabis announces $125M bought deal offering » 17:44
01/21/21
01/21
17:44
01/21/21
17:44
ACB

Aurora Cannabis

$11.17 /

-0.39 (-3.37%)

Aurora Cannabis has…

Aurora Cannabis has announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets and ATB Capital Markets, under which the underwriters have agreed to buy on bought deal basis 12M units of the company, at a price of $10.45 per Unit for gross proceeds of approximately $125M. Each Unit will be comprised of one common share of the company and one half of one common share purchase warrant of the company. Each Warrant will be exercisable to acquire one common share of the company for a period of 36 months following the closing date of the Offering at an exercise price of $12.60 per Warrant Share, subject to adjustment in certain events. The net proceeds of the offering will be used for general corporate purposes, which may include opportunistically reducing debt. The company believes that the Offering fits with its broader strategy to have a strong balance sheet while maintaining maximum flexibility to invest and build towards being a leader in global cannabinoids. The closing of the Offering is expected to take place on or about January 26.

ShowHide Related Items >><<
ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

01/06/21 BMO Capital
Federal cannabis reform in U.S. likely to take time, says BMO Capital
12/17/20 BMO Capital
Aurora Cannabis downgraded to Underperform from Market Perform at BMO Capital
12/04/20 Alliance Global Partners
Alliance Global sees low odds of MORE Act passing this congressional session
12/02/20 Alliance Global Partners
Alliance Global Partners sees UN cannabis reclassification helping legalization
ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

  • 11
    Nov
ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

Syndicate
Aurora Cannabis announces $125M bought deal financing » 16:30
01/21/21
01/21
16:30
01/21/21
16:30
ACB

Aurora Cannabis

$11.17 /

-0.39 (-3.37%)

Aurora Cannabis announced…

Aurora Cannabis announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets and ATB Capital Markets, under which the underwriters have agreed to buy on bought deal basis 12M units of the company at a price of $10.45 per unit for gross proceeds of approximately $125M. Each unit will be comprised of one common share of the company and one half of one common share purchase warrant of the company. The net proceeds of the offering will be used for general corporate purposes, which may include opportunistically reducing debt. The company believes that the offering fits with its broader strategy to have a strong balance sheet while maintaining maximum flexibility to invest and build towards being a leader in global cannabinoids. The closing of the offering is expected to take place on or about January 26, and will be subject to customary conditions, including approvals of the Toronto Stock Exchange and the New York Stock Exchange.

ShowHide Related Items >><<
ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

01/06/21 BMO Capital
Federal cannabis reform in U.S. likely to take time, says BMO Capital
12/17/20 BMO Capital
Aurora Cannabis downgraded to Underperform from Market Perform at BMO Capital
12/04/20 Alliance Global Partners
Alliance Global sees low odds of MORE Act passing this congressional session
12/02/20 Alliance Global Partners
Alliance Global Partners sees UN cannabis reclassification helping legalization
ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

  • 11
    Nov
ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

On The Fly
Rising High: An exclusive talk with emulsion provider SoRSE Technology » 11:31
01/21/21
01/21
11:31
01/21/21
11:31
IGC

India Globalization Capital

$1.51 /

-0.04 (-2.59%)

, ZYNE

Zynerba

$3.55 /

-0.05 (-1.39%)

, TCNNF

Trulieve Cannabis

$0.00 /

+ (+0.00%)

, TLRY

Tilray

$17.54 /

-1.24 (-6.60%)

, CANN

General Cannabis

$0.00 /

+ (+0.00%)

, CRON

Cronos Group

$10.73 /

-0.225 (-2.05%)

, CGC

Canopy Growth

$33.22 /

-0.41 (-1.22%)

, CTST

CannTrust

$0.64 /

+ (+0.00%)

, CVSI

CV Sciences

$0.00 /

+ (+0.00%)

, ACB

Aurora Cannabis

$10.96 /

-0.6 (-5.19%)

, APHA

Aphria

$12.54 /

-0.525 (-4.02%)

In this edition of…

ShowHide Related Items >><<
ZYNE Zynerba
$3.55 /

-0.05 (-1.39%)

TLRY Tilray
$17.54 /

-1.24 (-6.60%)

IGC India Globalization Capital
$1.51 /

-0.04 (-2.59%)

CVSI CV Sciences
$0.00 /

+ (+0.00%)

CTST CannTrust
$0.64 /

+ (+0.00%)

CRON Cronos Group
$10.73 /

-0.225 (-2.05%)

CGC Canopy Growth
$33.22 /

-0.41 (-1.22%)

CANN General Cannabis
$0.00 /

+ (+0.00%)

APHA Aphria
$12.54 /

-0.525 (-4.02%)

ACB Aurora Cannabis
$10.96 /

-0.6 (-5.19%)

IGC India Globalization Capital
$1.51 /

-0.04 (-2.59%)

12/04/20 Alliance Global Partners
Alliance Global sees low odds of MORE Act passing this congressional session
12/02/20 Alliance Global Partners
Alliance Global Partners sees UN cannabis reclassification helping legalization
08/31/20 Roth Capital
Roth Capital believes MORE Act will not pass in 2020
04/08/20 Raymond James
Ontario AG order positive for Canadian cannabis stocks, says Raymond James
ZYNE Zynerba
$3.55 /

-0.05 (-1.39%)

12/21/20 H.C. Wainwright
Zynerba price target lowered to $9 from $12 at H.C. Wainwright
07/01/20 H.C. Wainwright
Zynerba market cap 'greatly underprices' potential, says H.C. Wainwright
TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

01/19/21 Needham
Trulieve Cannabis price target raised to $60.50 from $36.25 at Needham
01/13/21 Canaccord
Trulieve Cannabis price target raised to C$75 from C$60 at Canaccord
TLRY Tilray
$17.54 /

-1.24 (-6.60%)

01/15/21 Alliance Global Partners
Aphria price target raised to C$20 from C$12 at Alliance Global Partners
01/15/21 BMO Capital
Aphria price target raised to C$15 from C$7 at BMO Capital
12/24/20 Raymond James
Raymond James says Village Farms situated well for cannabis sector consolidation
12/17/20 Canaccord
Aphria downgraded to Hold from Speculative Buy at Canaccord
CANN General Cannabis
$0.00 /

+ (+0.00%)

CRON Cronos Group
$10.73 /

-0.225 (-2.05%)

01/06/21 BMO Capital
Federal cannabis reform in U.S. likely to take time, says BMO Capital
11/16/20 Jefferies
Cronos Group price target lowered to C$5.00 from C$5.60 at Jefferies
CGC Canopy Growth
$33.22 /

-0.41 (-1.22%)

01/05/21 Cantor Fitzgerald
Canopy Growth price target raised to C$33 from C$29 at Cantor Fitzgerald
12/28/20 JPMorgan
Constellation Brands price target raised to $248 from $218 at JPMorgan
CTST CannTrust
$0.64 /

+ (+0.00%)

CVSI CV Sciences
$0.00 /

+ (+0.00%)

06/12/20 Cowen
CV Sciences initiated with a Market Perform at Cowen
ACB Aurora Cannabis
$10.96 /

-0.6 (-5.19%)

12/17/20 BMO Capital
Aurora Cannabis downgraded to Underperform from Market Perform at BMO Capital
APHA Aphria
$12.54 /

-0.525 (-4.02%)

01/19/21 Stifel
Aphria price target raised to $15.50 from $9.80 at Stifel
01/15/21 CIBC
Aphria price target raised to C$18 from C$12.50 at CIBC
ZYNE Zynerba
$3.55 /

-0.05 (-1.39%)

TLRY Tilray
$17.54 /

-1.24 (-6.60%)

TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

IGC India Globalization Capital
$1.51 /

-0.04 (-2.59%)

CRON Cronos Group
$10.73 /

-0.225 (-2.05%)

CGC Canopy Growth
$33.22 /

-0.41 (-1.22%)

APHA Aphria
$12.54 /

-0.525 (-4.02%)

ACB Aurora Cannabis
$10.96 /

-0.6 (-5.19%)

  • 11
    Nov
IGC India Globalization Capital
$1.51 /

-0.04 (-2.59%)

CTST CannTrust
$0.64 /

+ (+0.00%)

CGC Canopy Growth
$33.22 /

-0.41 (-1.22%)

IGC India Globalization Capital
$1.51 /

-0.04 (-2.59%)

ZYNE Zynerba
$3.55 /

-0.05 (-1.39%)

TLRY Tilray
$17.54 /

-1.24 (-6.60%)

IGC India Globalization Capital
$1.51 /

-0.04 (-2.59%)

CRON Cronos Group
$10.73 /

-0.225 (-2.05%)

CGC Canopy Growth
$33.22 /

-0.41 (-1.22%)

APHA Aphria
$12.54 /

-0.525 (-4.02%)

ACB Aurora Cannabis
$10.96 /

-0.6 (-5.19%)

Tuesday
Recommendations
Trulieve Cannabis price target raised to $60.50 from $36.25 at Needham » 09:09
01/19/21
01/19
09:09
01/19/21
09:09
TCNNF

Trulieve Cannabis

$0.00 /

+ (+0.00%)

Needham analyst Matt…

Needham analyst Matt McGinley raised the firm's price target on Trulieve Cannabis to $60.50 from $36.25 and keeps a Buy rating on the shares as part of a broader research note on cannabis operators after holding talks with select management teams at the Needham Growth Conference last week. The analyst states that his fundamental outlook for the industry and the company has not changed materially for FY21, but the prospects for federal reform have improved, along with prospects for funding growth given the recent capital market activity. McGinley contends that cannabis sector multiples have and will continue to re-rate higher.

ShowHide Related Items >><<
TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

01/13/21 Canaccord
Trulieve Cannabis price target raised to C$75 from C$60 at Canaccord
12/04/20 Alliance Global Partners
Alliance Global sees low odds of MORE Act passing this congressional session
12/02/20 Alliance Global Partners
Alliance Global Partners sees UN cannabis reclassification helping legalization
11/18/20 Craig-Hallum
Trulieve Cannabis price target raised to $50 from $45 at Craig-Hallum
TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

Recommendations
Aphria price target raised to $15.50 from $9.80 at Stifel » 08:15
01/19/21
01/19
08:15
01/19/21
08:15
APHA

Aphria

$12.41 /

+0.33 (+2.73%)

Stifel analyst W. Andrew…

Stifel analyst W. Andrew Carter raised the firm's price target on Aphria to $15.50 from $9.80 and keeps a Hold rating on the shares following Q2 earnings results that were ahead of his estimates and continued to "underscore Aphria's position of strength" even with softer Canadian adult use sales than expected. However, Canadian producers have outperformed significantly following the U.S. election and he believes the stock's "robust valuation" impedes material outperformance for a stock he sees as "likely to remain volatile," Carter said.

ShowHide Related Items >><<
APHA Aphria
$12.41 /

+0.33 (+2.73%)

APHA Aphria
$12.41 /

+0.33 (+2.73%)

01/15/21 CIBC
Aphria price target raised to C$18 from C$12.50 at CIBC
01/15/21 Alliance Global Partners
Aphria price target raised to C$20 from C$12 at Alliance Global Partners
01/15/21 BMO Capital
Aphria price target raised to C$15 from C$7 at BMO Capital
01/15/21 Canaccord
Aphria upgraded to Speculative Buy from Hold at Canaccord
APHA Aphria
$12.41 /

+0.33 (+2.73%)

APHA Aphria
$12.41 /

+0.33 (+2.73%)

APHA Aphria
$12.41 /

+0.33 (+2.73%)

APHA Aphria
$12.41 /

+0.33 (+2.73%)

Over a week ago
Recommendations
Aphria price target raised to C$18 from C$12.50 at CIBC » 11:35
01/15/21
01/15
11:35
01/15/21
11:35
APHA

Aphria

$12.98 /

+0.9 (+7.45%)

CIBC analyst John Zamparo…

CIBC analyst John Zamparo raised the firm's price target on Aphria to C$18 from C$12.50 and keeps an Outperformer rating on the shares.

ShowHide Related Items >><<
APHA Aphria
$12.98 /

+0.9 (+7.45%)

APHA Aphria
$12.98 /

+0.9 (+7.45%)

01/15/21 Alliance Global Partners
Aphria price target raised to C$20 from C$12 at Alliance Global Partners
01/15/21 BMO Capital
Aphria price target raised to C$15 from C$7 at BMO Capital
01/15/21 Canaccord
Aphria upgraded to Speculative Buy from Hold at Canaccord
01/06/21 BMO Capital
Federal cannabis reform in U.S. likely to take time, says BMO Capital
APHA Aphria
$12.98 /

+0.9 (+7.45%)

APHA Aphria
$12.98 /

+0.9 (+7.45%)

APHA Aphria
$12.98 /

+0.9 (+7.45%)

APHA Aphria
$12.98 /

+0.9 (+7.45%)

Recommendations
Aphria price target raised to C$20 from C$12 at Alliance Global Partners » 07:50
01/15/21
01/15
07:50
01/15/21
07:50
APHA

Aphria

$12.08 /

+2.08 (+20.80%)

, TLRY

Tilray

$18.56 /

+3.54 (+23.57%)

Alliance Global Partners…

Alliance Global Partners analyst Aaron Grey raised the firm's price target on Aphria (APHA) to C$20 from C$12 and keeps a Buy rating on the shares following the company's "solid" fiscal Q2 results. The company grew adult-use below the industry rate, but Aphria remained a market leader at a 13% share, Grey tells investors in a research note. The analyst stills view Aphria as one of the better operators in Canada, and notes the pending Tilray (TLRY) acquisition ill increase international and U.S. exposure.

ShowHide Related Items >><<
TLRY Tilray
$18.56 /

+3.54 (+23.57%)

APHA Aphria
$12.08 /

+2.08 (+20.80%)

APHA Aphria
$12.08 /

+2.08 (+20.80%)

01/15/21 BMO Capital
Aphria price target raised to C$15 from C$7 at BMO Capital
01/15/21 Canaccord
Aphria upgraded to Speculative Buy from Hold at Canaccord
01/06/21 BMO Capital
Federal cannabis reform in U.S. likely to take time, says BMO Capital
12/24/20 Raymond James
Raymond James says Village Farms situated well for cannabis sector consolidation
TLRY Tilray
$18.56 /

+3.54 (+23.57%)

12/17/20 Canaccord
Aphria downgraded to Hold from Speculative Buy at Canaccord
12/17/20 Stifel
Tilray upgraded to Hold from Sell at Stifel
TLRY Tilray
$18.56 /

+3.54 (+23.57%)

APHA Aphria
$12.08 /

+2.08 (+20.80%)

APHA Aphria
$12.08 /

+2.08 (+20.80%)

APHA Aphria
$12.08 /

+2.08 (+20.80%)

TLRY Tilray
$18.56 /

+3.54 (+23.57%)

APHA Aphria
$12.08 /

+2.08 (+20.80%)

Recommendations
Aphria price target raised to C$15 from C$7 at BMO Capital » 07:15
01/15/21
01/15
07:15
01/15/21
07:15
APHA

Aphria

$12.08 /

+2.08 (+20.80%)

, TLRY

Tilray

$18.56 /

+3.54 (+23.57%)

BMO Capital analyst Tamy…

BMO Capital analyst Tamy Chen raised the firm's price target on Aphria (APHA) to C$15 from C$7 and keeps a Market Perform rating on the shares. The company's Canada remains challenging and there may be possible integration risk from the Tilray (TLRY) merger, but seven quarters of positive EBITDA and improving cash flows have proven her reservations "incorrect", the analyst tells investors in a research note.

ShowHide Related Items >><<
TLRY Tilray
$18.56 /

+3.54 (+23.57%)

APHA Aphria
$12.08 /

+2.08 (+20.80%)

APHA Aphria
$12.08 /

+2.08 (+20.80%)

01/15/21 Canaccord
Aphria upgraded to Speculative Buy from Hold at Canaccord
01/06/21 BMO Capital
Federal cannabis reform in U.S. likely to take time, says BMO Capital
12/24/20 Raymond James
Raymond James says Village Farms situated well for cannabis sector consolidation
12/17/20 CIBC
Aphria price target raised to C$12.50 from C$9 at CIBC
TLRY Tilray
$18.56 /

+3.54 (+23.57%)

12/17/20 Canaccord
Aphria downgraded to Hold from Speculative Buy at Canaccord
12/17/20 Stifel
Tilray upgraded to Hold from Sell at Stifel
12/17/20 Stifel
Aphria downgraded to Hold from Buy at Stifel
TLRY Tilray
$18.56 /

+3.54 (+23.57%)

APHA Aphria
$12.08 /

+2.08 (+20.80%)

APHA Aphria
$12.08 /

+2.08 (+20.80%)

APHA Aphria
$12.08 /

+2.08 (+20.80%)

TLRY Tilray
$18.56 /

+3.54 (+23.57%)

APHA Aphria
$12.08 /

+2.08 (+20.80%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.